Precisio Biotix Therapeutics
DE - DoverBiotechnology
Focus: Precisio Biotix Therapeutics is a Delaware-based biotechnology company specializing in bacteriophage-based therapies for infectious diseases, oncology, and neurology applications. The company is in early clinical stage with three Phase 1/1-2 programs in wound care and orthopedic infections.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Precisio Biotix Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Precisio Biotix Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Bacteriophage cocktail spray
Wound InfectionClinical Trials (1)
NCT04323475Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients
Phase 1Help build intelligence for Precisio Biotix Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.